Table 2.
Patient characteristics of the rel cohort (n = 18).
| Patient no. | Age at primary diagnosis [months] | KMT2A-r partner | sex | EGR3 ΔCT Mean | IGHM ΔCTMean | CD79A ΔCTMean | BLK ΔCTMean | PTPN6 ΔCTMean |
|---|---|---|---|---|---|---|---|---|
| REZ1 | 1.3 | AFF1 | F | 2.8330 | 3.6274 | 2.5294 | 6.2860 | 4.2386 |
| REZ2 | 2.9 | MLLT1 | M | 4.1774 | 8.3719 | 6.2586 | 7.3628 | 4.5660 |
| REZ3 | 3.8 | AFF1 | F | 4.3014 | 11.1143 | 7.5835 | 9.1950 | 10.0947 |
| REZ4 | 2.5 | AFF1 | F | 6.6574 | 12.0503 | 10.1751 | 11.9828 | 9.3876 |
| REZ5 | 1.2 | AFF1 | F | 1.1889 | 10.5701 | 8.1192 | 9.9020 | 9.5213 |
| REZ6 | 10.7 | MLLT1 | M | 5.1781 | 5.0754 | 3.5868 | −0.4993 | 3.8987 |
| REZ7 | 4.3 | MLLT1 | M | 3.7298 | 6.0183 | 5.0341 | −0.4709 | 6.2223 |
| REZ8 | 3.6 | MLLT3 | F | 4.7424 | 3.6338 | 4.7103 | 0.1660 | 3.3973 |
| REZ9 | 9.1 | AFF1 | F | 2.2762 | 10.9410 | 7.9419 | 8.6553 | 9.9990 |
| REZ10 | 0.7 | AFF1 | F | 1.6308 | 13.4663 | 9.1956 | 10.7877 | 10.0112 |
| REZ11 | 4.4 | AFF1 | M | 6.5653 | 10.6022 | 9.1016 | 10.0768 | 11.0481 |
| REZ12 | 4.2 | AFF1 | M | 5.0302 | 5.1254 | 3.0619 | 4.9896 | 1.7865 |
| REZ13 | 2.0 | AFF1 | F | 2.5849 | 7.4593 | 4.5334 | 4.2896 | 1.5519 |
| REZ14 | 3.1 | AFF1 | F | 8.4397 | 10.9710 | 7.2141 | 9.6779 | 1.5646 |
| REZ15 | 7.6 | AFF1 | F | 7.8336 | 4.8100 | 5.3276 | 6.5240 | 4.4725 |
| REZ16 | 6.7 | AFF1 | M | 9.5416 | 9.4965 | 5.6740 | 8.0000 | 4.4870 |
| REZ17 | 5.3 | AFF1 | M | 9.8667 | 5.2598 | 3.3857 | −0.1229 | 5.3876 |
| REZ18 | 7.2 | AFF1 | M | 6.7247 | 5.9524 | 3.2850 | 0.2192 | 4.3320 |
Samples were taken from PB at relapse diagnosis. Gene expression values are indicated as the ΔCT mean of technical triplicates.
F female, M male.